机构:[1]Nanjing Med Univ, Nanjing Hosp 1, Nanjing 210006, Jiangsu, Peoples R China江苏省人民医院[2]Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China[3]Chinese Univ Hong Kong, Ctr Clin Res & Biostat, Hong Kong, Hong Kong, Peoples R China[4]CUHK Shenzhen Res Inst, Shenzhen, Peoples R China[5]West China Hosp, Chengdu, Sichuan, Peoples R China四川大学华西医院[6]Hebei Med Univ, Hosp 4, Canc Inst, Shijiazhuang, Hebei, Peoples R China河北医科大学第四医院[7]Chinese Univ Hong Kong, Dept Anaesthesia & Intens Care, Hong Kong, Hong Kong, Peoples R China[8]City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Hong Kong, Peoples R China
第一作者机构:[1]Nanjing Med Univ, Nanjing Hosp 1, Nanjing 210006, Jiangsu, Peoples R China
推荐引用方式(GB/T 7714):
Chen Jinfei,Wang Maggie Haitian,Men Ruoting,et al.Thymidylate synthase 4R polymorphism is a prognostic biomarker in chinese gastric cancer patients[J].INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE.2017,40:S61-S61.
APA:
Chen, Jinfei,Wang, Maggie Haitian,Men, Ruoting,Gu, Dongying,Liang, Di...&Zee, Benny Chung Ying.(2017).Thymidylate synthase 4R polymorphism is a prognostic biomarker in chinese gastric cancer patients.INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE,40,
MLA:
Chen, Jinfei,et al."Thymidylate synthase 4R polymorphism is a prognostic biomarker in chinese gastric cancer patients".INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 40.(2017):S61-S61